SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Robert S. Brown, Jacqueline G. O'Leary, K. Rajender Reddy, Alexander Kuo, Giuseppe J. Morelli, James R. Burton, R. Todd Stravitz, Christine Durand, Adrian M. Bisceglie, Paul Kwo, Catherine T. Frenette, Thomas G. Stewart, David R. Nelson, Michael W. Fried, Norah A. Terrault, Interferon-free therapy for genotype 1 hepatitis C in liver transplant recipients: Real-world experience from the hepatitis C therapeutic registry and research network, Liver Transplantation, 2016, 22, 1
  2. 2
    A. Ajlan, A. Al-Jedai, H. Elsiesy, D. Alkortas, W. Al-Hamoudi, R. Alarieh, M. Al-Sebayel, D. Broering, F. Aba Alkhail, Sofosbuvir-Based Therapy for Genotype 4 HCV Recurrence Post-Liver Transplant Treatment-Experienced Patients, Canadian Journal of Gastroenterology and Hepatology, 2016, 2016, 1

    CrossRef

  3. 3
    Fritz Klein, Ruth Neuhaus, Dennis Eurich, Jörg Hofmann, Sandra Bayraktar, Johann Pratschke, Marcus Bahra, Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy, Hepatitis Research and Treatment, 2016, 2016, 1

    CrossRef

  4. 4
    Sammy Saab, Vignan Manne, Sherona Bau, Justin A. Reynolds, Ruby Allen, Leonard Goldstein, Francisco Durazo, Mohammed El-Kabany, Steven Han, Ronald W. Busuttil, Boceprevir in liver transplant recipients, Liver International, 2015, 35, 1
  5. 5
    Anna Hüsing, Iyad Kabar, Hartmut Schmidt, Hauke Heinzow, Hepatitis C in Special Patient Cohorts: New Opportunities in Decompensated Liver Cirrhosis, End-Stage Renal Disease and Transplant Medicine, International Journal of Molecular Sciences, 2015, 16, 8, 18033

    CrossRef

  6. 6
    Zoe Mariño, Maria-Carlota Londoño, Xavier Forns, Hepatitis C treatment for patients post liver transplant, Current Opinion in Organ Transplantation, 2015, 20, 3, 251

    CrossRef

  7. 7
    Bruno Roche, Audrey Coilly, Anne-Marie Roque-Afonso, Didier Samuel, Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance, Viruses, 2015, 7, 9, 5155

    CrossRef

  8. 8
    Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée, Didier Samuel, Management of post transplant hepatitis C in the direct antiviral agents era, Hepatology International, 2015, 9, 2, 192

    CrossRef

  9. You have free access to this content9
    Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée, Didier Samuel, Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals, Liver International, 2015, 35,
  10. 10
    Hyeyoung Kim, Kwang-Woong Lee, Nam-Joon Yi, Hae Won Lee, YoungRok Choi, Suk-Won Suh, Jaehong Jeong, Kyung-Suk Suh, Response-Guided Therapy for Hepatitis C Virus Recurrence Based on Early Protocol Biopsy after Liver Transplantation, Journal of Korean Medical Science, 2015, 30, 11, 1577

    CrossRef

  11. 11
    Elizabeth C. Verna, Varun Saxena, James R. Burton, Jacqueline G. O’Leary, Jennifer L. Dodge, Richard T. Stravitz, Josh Levitsky, James F. Trotter, Gregory T. Everson, Robert S. Brown, Norah A. Terrault, Telaprevir- and Boceprevir-based Triple Therapy for Hepatitis C in Liver Transplant Recipients With Advanced Recurrent Disease, Transplantation, 2015, 99, 8, 1644

    CrossRef

  12. 12
    Jennifer C. Price, Norah A. Terrault, Treatment of hepatitis C in liver transplant patients: Interferon out, direct antiviral combos in, Liver Transplantation, 2015, 21, 4
  13. 13
    Marina Berenguer, John R. Lake, Transplantation of the Liver, 2015,

    CrossRef

  14. 14
    James R. Burton, Jacqueline G. O’Leary, Elizabeth C. Verna, Varun Saxena, Jennifer L. Dodge, Richard T. Stravitz, Joshua Levitsky, James F. Trotter, Gregory T. Everson, Robert S. Brown, Norah A. Terrault, A US multicenter study of hepatitis C treatment of liver transplant recipients with protease-inhibitor triple therapy, Journal of Hepatology, 2014, 61, 3, 508

    CrossRef

  15. 15
    Sabela Lens, Zoe Mariño, Xavier Forns, Efficacy of new direct acting antivirals in transplant recipients and patients with advanced disease, Digestive and Liver Disease, 2014, 46, S197

    CrossRef

  16. You have free access to this content16
    Audrey Coilly, Bruno Roche, Jean-Charles Duclos-Vallée, Didier Samuel, Management of HCV transplant patients with triple therapy, Liver International, 2014, 34,
  17. 17
    Bruno Roche, Audrey Coilly, Jean-Charles Duclos-Vallée, Didier Samuel, Optimal Management of HCV Transplant Patients, Current Hepatology Reports, 2014, 13, 4, 304

    CrossRef

  18. 18
    N. Terrault, K. R. Reddy, F. Poordad, M. Curry, T. Schiano, J. Johl, O. Shaikh, L. Dove, K. Shetty, M. Millis, E. Schiff, F. Regenstein, D. Barnes, B. Barin, M. Peters, M. Roland, P. Stock, Peginterferon and Ribavirin for Treatment of Recurrent Hepatitis C Disease in HCV–HIV Coinfected Liver Transplant Recipients, American Journal of Transplantation, 2014, 14, 5
  19. 19
    Deepak Joshi, Massimo Pinzani, Ivana Carey, Kosh Agarwal, Recurrent HCV after liver transplantation—mechanisms, assessment and therapy, Nature Reviews Gastroenterology and Hepatology, 2014, 11, 12, 710

    CrossRef

  20. 20
    Audrey Coilly, Bruno Roche, Jérôme Dumortier, Vincent Leroy, Danielle Botta-Fridlund, Sylvie Radenne, Georges-Philippe Pageaux, Si-Nafaa Si-Ahmed, Olivier Guillaud, Teresa Maria Antonini, Stéphanie Haïm-Boukobza, Anne-Marie Roque-Afonso, Didier Samuel, Jean-Charles Duclos-Vallée, Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: A multicenter experience, Journal of Hepatology, 2014, 60, 1, 78

    CrossRef

  21. 21
    Martina Gambato, Sabela Lens, Miquel Navasa, Xavier Forns, Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation, Journal of Hepatology, 2014, 61, 1, S120

    CrossRef

  22. You have free access to this content22
    Audrey Coilly, Bruno Roche, Didier Samuel, Current management and perspectives for HCV recurrence after liver transplantation, Liver International, 2013, 33,
  23. 23
    Marina Berenguer, Bruno Roche, Victoria Aguilera, Jean-Charles Duclos-Vallée, Laia Navarro, Angel Rubín, Jose-Antonio Pons, Manuel de la Mata, Martín Prieto, Didier Samuel, Efficacy of the retreatment of hepatitis C virus infections after liver transplantation: Role of an aggressive approach, Liver Transplantation, 2013, 19, 1
  24. 24
    Giacomo Germani, Emmanuel Tsochatzis, Vasilios Papastergiou, Andrew K Burroughs, HCV in liver transplantation, Seminars in Immunopathology, 2013, 35, 1, 101

    CrossRef

  25. 25
    Susanne Beckebaum, Iyad Kabar, Vito R. Cicinnati, Hepatitis B and C in liver transplantation: new strategies to combat the enemies, Reviews in Medical Virology, 2013, 23, 3
  26. You have free access to this content26
    Michael R. Lucey, Norah Terrault, Lolu Ojo, J. Eileen Hay, James Neuberger, Emily Blumberg, Lewis W. Teperman, Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation, Liver Transplantation, 2013, 19, 1
  27. 27
    Shih-Hsien Hsu, Ming-Lun Yeh, Shen-Nien Wang, New Insights in Recurrent HCV Infection after Liver Transplantation, Clinical and Developmental Immunology, 2013, 2013, 1

    CrossRef

  28. 28
    Jennifer C. Price, Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation, Current Hepatitis Reports, 2013, 12, 4, 227

    CrossRef

  29. 29
    Marina Berenguer, Detlef Schuppan, Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatment, Journal of Hepatology, 2013, 58, 5, 1028

    CrossRef

  30. You have free access to this content30
    D. Joshi, I. Carey, K. Agarwal, Review article: the treatment of genotype 1 chronic hepatitis C virus infection in liver transplant candidates and recipients, Alimentary Pharmacology & Therapeutics, 2013, 37, 7
  31. 31
    Faisal M. Sanai, Dujana Mousa, Abdallah Al-Mdani, Ghada Al-Shoail, Hamad Al-Ashgar, Khalid Al Meshari, Ahmed Al-Qahtani, Mayssa Saadeh, Khalid I. Bzeizi, Hassan Aleid, Safety and efficacy of peginterferon-α2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C, Journal of Hepatology, 2013, 58, 6, 1096

    CrossRef

  32. 32
    Jack Harbell, Norah A. Terrault, Peter Stock, Solid Organ Transplants in HIV-Infected Patients, Current HIV/AIDS Reports, 2013, 10, 3, 217

    CrossRef

  33. 33
    Ji-Yuan Zhang, Yuan-Yuan Li, Zheng Zhang, Fu-Sheng Wang, The prediction of immunological dysfunction during antiviral therapy for HCV after liver transplantation: can we improve outcomes?, Hepatology International, 2013, 7, 4, 948

    CrossRef

  34. 34
    Roberto Galuppo, Angie McCall, Roberto Gedaly, The Role of Bridging Therapy in Hepatocellular Carcinoma, International Journal of Hepatology, 2013, 2013, 1

    CrossRef

  35. 35
    Kosh Agarwal, Ashley Barnabas, Treatment of chronic hepatitis C virus infection after liver transplantation, Digestive and Liver Disease, 2013, 45, S349

    CrossRef

  36. 36
    Marina Berenguer, Victoria Aguilera, Angel Rubín, Cecilia Ortíz, Martina Jimenez, Martín Prieto, Comparison of two non-contemporaneous HCV-liver transplant cohorts: Strategies to improve the efficacy of antiviral therapy, Journal of Hepatology, 2012, 56, 6, 1310

    CrossRef

  37. 37
    Tommaso Maria Manzia, Roberta Angelico, Luca Toti, Quirino Lai, Paolo Ciano, Mario Angelico, Giuseppe Tisone, Hepatitis C virus recurrence and immunosuppression-free state after liver transplantation, Expert Review of Clinical Immunology, 2012, 8, 7, 635

    CrossRef

  38. 38
    Varun Saxena, Norah Terrault, Hepatitis C virus treatment and liver transplantation in the era of new antiviral therapies, Current Opinion in Organ Transplantation, 2012, 17, 3, 216

    CrossRef

  39. 39
    Bruno Roche, Didier Samuel, Hepatitis C virus treatment pre- and post-liver transplantation, Liver International, 2012, 32,
  40. 40
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Liver Transplantation and Hepatitis C, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  41. 41
    Norah Terrault, Liver transplantation in the setting of chronic HCV, Best Practice & Research Clinical Gastroenterology, 2012, 26, 4, 531

    CrossRef

  42. 42
    Shishir Shetty, David H Adams, Stefan G Hubscher, Post-transplant liver biopsy and the immune response: lessons for the clinician, Expert Review of Clinical Immunology, 2012, 8, 7, 645

    CrossRef

  43. 43
    Marina Berenguer, Ramón Charco, Juan Manuel Pascasio, Jose Ignacio Herrero, Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation, Liver International, 2012, 32, 5
  44. 44
    Eleonora De Martin, Kryssia I Rodriguez-Castro, Alessandro Vitale, Giacomo Zanus, Marco Senzolo, Francesco Paolo Russo, Patrizia Burra, Antiviral treatment for HCV recurrence after liver transplantation: when, how much and for how long?, Future Virology, 2011, 6, 10, 1179

    CrossRef

  45. 45
    III Consensus Meeting of the Spanish Society of Liver Transplantation. Hepatitis C, Living-donor Liver Transplantation, Quality of Liver Grafts and of Liver Transplantation Programs, Cirugía Española (English Edition), 2011, 89, 8, 487

    CrossRef

  46. 46
    III Reunión de consenso de la Sociedad Española de Trasplante Hepático (SETH). Hepatitis C, trasplante hepático de donante vivo, calidad de los injertos hepáticos y calidad de los programas de trasplante hepático, Cirugía Española, 2011, 89, 8, 487

    CrossRef

  47. 47
    J. Ignacio Herrero, III Reunión de consenso de la Sociedad Española de Trasplante Hepático (SETH). Hepatitis C, trasplante hepático de donante vivo, calidad de los injertos hepáticos y calidad de los programas de trasplante hepático, Gastroenterología y Hepatología, 2011, 34, 9, 641

    CrossRef

  48. 48
    Nazia Selzner, Maha Guindi, Eberhard L. Renner, Marina Berenguer, Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients, Journal of Hepatology, 2011, 55, 1, 207

    CrossRef

  49. 49
    Bruno Roche, Didier Samuel, Is early antiviral therapy for recurrent hepatitis C after liver transplantation superior to later treatment? The answer is no, Liver Transplantation, 2011, 17, 5
  50. 50
    A. Rubín, V. Aguilera, M. Berenguer, Liver transplantation and hepatitis C, Clinics and Research in Hepatology and Gastroenterology, 2011, 35, 12, 805

    CrossRef

  51. 51
    Alpna R. Limaye, Roberto J. Firpi, Management of Recurrent Hepatitis C Infection after Liver Transplantation, Clinics in Liver Disease, 2011, 15, 4, 845

    CrossRef

  52. 52
    Marie-Luise Berres, Christian Trautwein, Maximilian Schmeding, Dennis Eurich, Frank Tacke, Marcus Bahra, Peter Neuhaus, Ulf P. Neumann, Hermann E. Wasmuth, Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection, Hepatology, 2011, 53, 2
  53. 53
    Waleed Al-hamoudi, Hazem Mohamed, Faisal Abaalkhail, Yaser Kamel, Nasser Al-Masri, Naglaa Allam, Saleh Alqahtani, Mohammed Al-Sofayan, Hatem Khalaf, Mohammed Al-Sebayel, Ahmed Al-jedai, Ayman Abdo, Treatment of Genotype 4 Hepatitis C Recurring After Liver Transplantation Using a Combination of Pegylated Interferon Alfa-2a and Ribavirin, Digestive Diseases and Sciences, 2011, 56, 6, 1848

    CrossRef

  54. 54
    Marina Berenguer, Treatment of hepatitis C in the post-transplant setting, Digestive and Liver Disease Supplements, 2011, 5, 1, 26

    CrossRef

  55. You have free access to this content55
    Bruno Roche, Didier Samuel, Hepatitis C virus: Up to the minute, Liver Transplantation, 2010, 16, S2
  56. 56
    José A. Carrión, Miquel Navasa, Xavier Forns, Retransplantation in patients with hepatitis C recurrence after liver transplantation, Journal of Hepatology, 2010, 53, 5, 962

    CrossRef

  57. 57
    Imre Fehérvári, Májátültetésr, Magyar Sebészet, 2009, 62, 4, 251

    CrossRef

  58. 58
    Hee Young Kang, Ji Won Lim, Min Chul Shin, Pegylated Interferon Associated Retinopathy in Chronic Hepatitis Patients, Journal of the Korean Ophthalmological Society, 2009, 50, 3, 383

    CrossRef

  59. 59
    Hui-Hui Tan, Thomas D. Schiano, Treatment of hepatitis C in the potential liver transplant recipient, Current Hepatitis Reports, 2009, 8, 2, 81

    CrossRef

  60. 60
    Andrew K. Burroughs, James O'Beirne, Hepatic Transplantation,
  61. 61
    Keyur Patel, Hans L Tillmann, John G McHutchison, Hepatitis C,
  62. 62
    Norah Terrault, Liver Transplantation in Patients with Hepatitis B, C or HIV Infection,
  63. 63
    Kiran Bambha, Norah A. Terrault, Long-Term Management of Recurrent Primary Liver Disease,
  64. 64
    Brett E Fortune, Hugo R Rosen, James R Burton, Management of HCV Infection and Liver Transplantation,
  65. 65
    Kymberly D. S. Watt, Marie A. Laryea, Recurrent Disease Following Liver Transplantation,